Video
CAR-T Cell Therapies Entering the Mainstream of Cancer Clinical Trials & Treatment
Author(s):
KEY LEARNING OBJECTIVES
- Audience will have an understanding how Medidata can have an impact with Clinical Trial pharma and bio tech firms that are working in this therapeutic area
- What are the challenges that CAR-T developers face and how can data help address those challenges
- How is Medidata AI “data” different from other data providers
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Videos
Related Content
